Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare Summary • An Animal Health care company with global presence in a fast growing market • Sales in 50 countries, both with fully owned subsidiaries and external distributors • ProDen PlaqueOff® – a world leading product within oral care– complemented by a wide range of nutraceuticals (NutriScience) • Own production facility on Ireland with a wide product offering • A fragmented market – continued expansion through acquisitions • High growth and profitability • Listed On NASDAQ First North since 14 June 2016
Pets – from something you own to a member of the family • 68% of US households have a pet - increased every year over two decades • 94% sees the pet as a family member • The pets live longer – age related symptoms increase • Increased demand for organic feed and nutraceuticals • Demand of premium products grows • 46% of the pet owners have bought a nutraceutical at least once *) USA
Swedencare and the
Headcount:
Swedencare AB: 5
Biodistra: 1
World
Swedencare Nordic: 1
Swedencare UK: 4
Swedencare Ireland: 12
Swedencare US: 4
Swedencare Buccosanté: 2
180 million pets in
Europe
70M+ pets in
China/Japan
Pet market in China
Nutraceuticals, 2500
170 million pets in the grows by double digits.
MUSD in Europe and
U.S. Both by number of pets
USA – Growth 10–
and spending
15% per year
Dog - Cat - Horse
NUTRACEUTICALS
FEED
ACCESSORIES PRESCRIBED PRODUCTS
Company Timeline
1990’s 2017 (March)
2006
Research & discovery 2001 2016 (January) Production of
Patents in 2016 (July)
of advantages of Swedencare start Swedencare acquire PlaqueOff in own
Europe and USA Swedencare
product selling within the former distributors in factory in Ireland
are registered acquire Biodistra
Nordic France, UK and USA
AB
2005 2016 (June) 2016 (November) 2018 (January)
2000 2015
International expansion Company is listed Conversion to IFRS
Establishment of current New Business Swedencare acquire
in Europe is launched on Nasdaq First (International
business of Swedencare Plan developed the Irish company
North Financial Reporting
with new owners NutriScience (Ecuphar
Standard)
Ltd.)
Strategy in three parts
Product Portfolio and
Distribution Marketing
Channels
PlaqueOff *B2C and B2B
5 Sales Offices
NutriScience Exhibitions
>25
New products *Distributor
distributors
support
Sales in 50
*Training
countries
*Digital
Vet
Pet retail
Pharmacies
Retail
Proden PlaqueOff – a leading oral health product • Systemic effect on Oral Health • Patent- and Trade mark protected in all our major markets • Several clinical studies • Marketed in several sizes and forms – powder, Dental Bites, Dental Bone, in feed ( fall 2017) • 1,4million pots, annual consumption for 0,5 million dogs. Approx. 409 million registered dogs in the world means that we reach 0,12% of the potential market • Retail value, over 35 MUSD
New products NutriScience by Swedencare for dogs and cats A new group of products within several focus areas for dogs and cats. • Joints and mobility • Skin and coat • Multivitamin supplement • Calming supplement NutriScience by Swedencare for horses We are expanding the selection and we are now able to offer products which also soothes and prevents common problems with horses. • Digestive supplement • For a healthy stomach • For strength and performance • Cooling gel • Salt replacement
Clinical Studies – VOHC The difference between the placebo product and the tested product (ProDen PlaqueOff®) was 30-70% P1 Placebo P2 ProDen PlaqueOff®
Key Performance Indicators – Q1 2018
EBIT
REVENUE SOLVENCY
6 012 Tkr
21 798 Tkr 27,6% 75,9 %
CHANGE IN CASH
REVENUES
-4,9% 22 624 TkrKey Performance Indicators
jan-mar jan-mar jan-dec
(TSEK) 2018 2017 2017
Net Revenue 21 685 22 910 85 490
Total Revenue 21 798 22 910 85 660
EBIT 6 012 6 951 21 896
Net Income 4 801 5 236 17 014
Balance Sheet Total 105 448 94 772 99 848
Equity 80 007 61 939 74 203
Change of Revenue (%) -4,9% 64,1% 58,2%
Gross Margin (%) 73,0% 73,0% 74,4%
EBIT-margin (%) 27,6% 30,3% 25,6%
Net Income margin (%) 22,0% 22,9% 19,9%
Solvency (%) 75,9% 65,4% 74,3%
Interestbearing netdebt -4 626 4 415 -6 013
Cash 22 624 19 373 24 077
Outstanding Shares 15 770 622 15 770 622 15 770 622
Average outstanding shares 15 770 622 15 770 622 15 770 622
Net Income per share (SEK) 0,30 0,33 1,08
Equity per share (SEK) 5,07 3,93 4,71Rolling 4 Quarters - Sales
Rolling 4 Quarters - EBITDA
Sales per Region Q1 2018 Q1 2017
Sales per Product Q1 2018 Q1 2017
Swedencare Group – Balance Sheet March 2017
31-mar 31-dec 31-mars
2018 2017 2017
Goodwill 49 848 49 848 49 848
Other intangible assets 461 515 816
Buildings and land 3 385 14 36
Tangible assets 3 176 3 034 1 781
Financial assets 530 635 645
Total non current assets 57 400 54 046 53 126
Inventory 9 190 8 236 7 151
Accounts receivable 14 494 10 374 13 351
Other ST receivables 1 740 3 115 1 771
Cash 22 624 24 077 19 373
Total current assets 48 048 45 802 41 646
TOTAL ASSETS 105 448 99 848 94 772
Total equity 80 007 74 203 61 939
Long term liabilities 9 998 10 064 15 540
Creditline - - 248
Accounts payable 2 874 1 859 2 956
Other ST Liabilities 12 569 13 722 14 089
Total liabilities 25 441 25 645 32 833
TOTAL EQUITY AND LIABILITIES 105 448 99 848 94 772Stock Trend Over Time Introduction price: 14 SEK
Owners 2018-03-31 Antal aktier ägarandel Håkan Svanberg & Co Health Care AB 5 070 982 32,15% Mastan AB (Håkan Lagerberg genom bolag) 2 105 362 13,35% JCC Group Invest Sweden AB (Johan Bergdahl genom bolag) 2 102 351 13,33% Swedia Capital AB 800 786 5,08% AMF Aktiefond Småbolag 755 000 4,79% Aktia Nordic Micro Cap 516 614 3,28% SHB Fonder 480 000 3,04% Avanza 319 753 2,03% Nordnet Pensionsförsäkring AB 319 600 2,03% Martin Shimko - VD Swedencare USA 300 000 1,90% ML, Pierce Fenner & Smith Inc. 222 173 1,41% Grandeur, Fund BBHBOS 217 778 1,38% Granit Fonder Småbolag 216 265 1,37% Hans Persson - VD Swedencare Frankrike 199 750 1,27% Grenspecialisten 197 454 1,25% KBC Securities (Ecuphar NV) 195 122 1,24% Tedcap AB (Thomas Eklund genom bolag) 193 459 1,23% Lin Micka 150 772 0,96% Per Malmström Consulting AB 123 000 0,78% Anders Lönner 109 066 0,69% Övriga 1 175 335 7,45% Totalt 15 770 622 100,00% Free Float* 6 175 468 39,16% Innehav inkluderar närstående * Aktier som inte ägs av styrelsemedlemmar, deras närstående, eller aktieägare med mer än 10%
Priorities in 2018 • Dental Care Bones • Expanding NutriScience range • China launch • Co-ops with feed partners • Review acquisition opportunities • Digital presence and marketing support • Further strengthen partnerships with major players in Vet- and Pet Specialty retailers
Financial Strategy long term
Sales Forecast Trend
250
200
150
2017 ACTUAL 86M
100
Budget 2017: 80M
50
0
2015 2016 2017 2018 2019 2020You can also read
